Requirements to Reach Pharma C-Suite – Asrar Qureshi’s Blog Post #1300

Requirements to Reach Pharma C-Suite – Asrar Qureshi’s Blog Post #1300

Dear Colleagues! This is Asrar Qureshi’s Blog Post #1300 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here.

Credit: Joseph Okon

Credit: Solehuddin Mohammad

Credit: Vlada Karpovich

Preamble

This blogpost takes insights from an article published in PharmaExec.com. Link at the end.

What Does It Really Take to Reach the C-Suite? The Leadership Skills That Matter in Pharma

Reaching the C-suite is often viewed as the ultimate reward for a successful career.

Years of technical expertise, strong performance, promotions, and increasingly senior responsibilities eventually lead to the corner office. But is exceptional performance in one function enough to prepare someone to become a CEO, Chief Medical Officer, Chief Commercial Officer, or head of R&D? Increasingly, the answer is no.

A recent Pharmaceutical Executive article, drawing on the experience of Dr. Nick Botwood, chief medical officer and head of research and development at Syndax Pharmaceuticals, offers an important perspective on what C-suite readiness really requires. Botwood's career spans clinical development, regulatory strategy, medical affairs, and commercial strategy. His central message is straightforward: C-suite leadership is less about becoming the best expert in one discipline and more about developing the experience, breadth, judgment, and leadership capability to integrate multiple disciplines. For pharmaceutical executives aspiring to the C-suite, this distinction is critical.

The journey from functional excellence to enterprise leadership requires a fundamental change in how one thinks, communicates, makes decisions, and develops people. 

Functional Excellence Is Only the Beginning

Most pharmaceutical executives begin their careers by becoming experts in something. They may be outstanding in sales and marketing, medical affairs, regulatory affairs, finance, manufacturing, supply chain, clinical development, or R&D. Functional expertise is essential. But as responsibility increases, the nature of the job changes.

A functional leader can focus primarily on the performance of a particular function. A C-suite executive must understand how that function interacts with every other part of the organization.

Clinical development affects regulatory strategy. Regulatory decisions affect commercialization. Medical strategy affects market access. Manufacturing affects supply and profitability. Commercial decisions affect investment in R&D. Finance influences strategic choices across all of them. The C-suite therefore requires enterprise thinking.

The First Requirement: Build Exceptional Leaders Around You

One of the strongest insights in the article is that senior leadership is fundamentally a talent game.

Botwood emphasizes that, as head of R&D and CMO, one of his most important responsibilities is hiring exceptional functional leaders and integrating them into a coherent strategy. His experience at Syndax demonstrates that successful drug development depends upon leaders who can translate compelling science into clinical development plans, regulatory submissions, and ultimately successful commercialization.

This has an important implication for aspiring C-suite executives. Your career progression eventually becomes less about what you personally can do and more about what the people you lead can accomplish.

 Experience Across Functions Creates Executive Fluency

One of the article's most valuable ideas is the concept of cross-sector "fluency."

Botwood argues that experience across clinical development, regulatory strategy, medical affairs, and other areas gives leaders the ability to understand different professional languages and perspectives.

This does not mean that every executive must become an expert in every function. That would be impossible. Rather, C-suite leaders need enough understanding to engage intelligently with specialists. The executive fluency enables leaders to connect dots that functional specialists may see separately.

The Ability to Translate Complexity into Clarity

Pharmaceuticals may be one of the most complex industries in the world.

Drug development involves science, medicine, statistics, regulation, manufacturing, intellectual property, market access, economics, commercial strategy, and increasingly technology and artificial intelligence. Yet boards and investors do not have the time, or necessarily the expertise, to understand every scientific detail.

This creates the need for a crucial C-suite capability: the ability to simplify complexity without oversimplifying the truth.

Experience Cannot Be Downloaded

There is another particularly important message for aspiring executives.

Some aspects of leadership cannot be learned simply by reading books or attending courses. They must be experienced.

Botwood argues that there is no substitute for having been in different situations and having personally navigated problems and opportunities. Experience develops judgment, the ability to recognize patterns, anticipate consequences, and make decisions when information is incomplete. This is why career breadth matters.

A leader who has experienced a failed product launch learns something different from one who has only experienced success. Someone who has managed a regulatory setback develops a different perspective from someone who has never faced one. An executive who has worked through a major organizational restructuring understands change differently. C-suite readiness therefore comes from deliberately accumulating experiences, not simply accumulating titles.

Diverse Views Are Valuable, but Alignment Is Essential

Strong organizations need disagreement. If everyone around the leadership table thinks alike, important risks may go unnoticed. Different functions naturally see different dimensions of the same problem. All of these perspectives are valuable.

But diversity of opinion without alignment can produce organizational paralysis. Botwood makes an important distinction: diverse perspectives must ultimately be brought together around a shared vision. He observes that when things go wrong, it is often because people are not aligned around a common ambition rather than because they lack technical competence. This is a profound leadership lesson.

Shared Vision Requires Continuous Communication

Alignment does not happen once. It must be continuously reinforced. This is particularly important in pharmaceutical organizations where projects can take years and involve hundreds or thousands of people.

A shared vision provides the connective tissue. Without it, functions may become highly effective individually while the organization moves in different directions.

What Aspiring Pharma Executives Should Do Now

The article's lessons suggest a practical development agenda for anyone aspiring to the C-suite.

1. Become excellent at your current function: Breadth without depth creates shallow leadership. Build genuine credibility first.

2. Seek cross-functional assignments: Volunteer for projects involving other functions. Learn how colleagues think.

3. Ask for difficult assignments: A difficult turnaround, product launch, regulatory challenge, restructuring, or market entry may teach more than another comfortable promotion.

4. Develop business fluency: Understand financial statements, investment decisions, market dynamics, risk, strategy, and value creation.

5. Practice communicating complexity: Learn to explain sophisticated issues in language that boards, investors, physicians, employees, and patients can understand.

6. Build leaders, not followers: Your readiness for senior leadership is increasingly demonstrated by the quality of people you develop.

7. Learn to align people: Being able to win an argument is not the same as being able to build organizational commitment.

8. Develop judgment: Seek experiences that expose you to uncertainty, failure, competing priorities, and difficult decisions.

Sum Up

The path to the C-suite in pharmaceuticals is not simply a climb upward. It is a transformation outward. You move from expertise to integration, from individual achievement to organizational achievement, from managing activities to creating alignment, and from solving problems yourself to building people who can solve them.

The pharmaceutical industry needs leaders who can understand science without becoming trapped in science, understand business without losing sight of patients, and navigate complexity without making it unnecessarily complicated.

Concluded.

Disclaimers: Pictures in these blogs are taken from free resources at Pexels, Pixabay, Unsplash, and Google. Credit is given where available. If a copyright claim is lodged, we shall remove the picture with appropriate regrets.

For most blogs, I research from several sources which are open to public. Their links are mentioned under references. There is no intent to infringe upon anyone’s copyrights. If, any claim is lodged, it will be acknowledged and duly recognized immediately. 

Reference:

https://www.pharmexec.com/view/what-c-suite-readiness-really-requires